Drugplain

REFRESH OPTIVE 5 mg/mL

carboxymethylcellulose sodium and glycerin · SOLUTION/ DROPS · Allergan, Inc.

No Recall History
Plain English

Refresh Optive is an over-the-counter eye drop solution used to relieve dry eye symptoms by lubricating and moisturizing the eyes. It contains carboxymethylcellulose sodium and glycerin, which work together to provide temporary comfort for dry, irritated eyes.

Key Facts

Brand Name
REFRESH OPTIVE
Generic Name
carboxymethylcellulose sodium and glycerin
NDC Code (Product)
0023-3240
Manufacturer
Allergan, Inc.
Strength
5 mg/mL
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Marketing Status
Application #
M018
Drug Class
Non-Standardized Chemical Allergen [EPC]
Marketing Start
09/06/2006

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

eye irritation561 reports
eye pain380 reports
vision blurred310 reports
drug ineffective264 reports
ocular hyperaemia217 reports
dry eye215 reports
cataract214 reports
foreign body sensation in eyes126 reports
eye discharge121 reports
eye pruritus110 reports

Frequently Asked Questions

What is REFRESH OPTIVE used for?

Refresh Optive is an over-the-counter eye drop solution used to relieve dry eye symptoms by lubricating and moisturizing the eyes. It contains carboxymethylcellulose sodium and glycerin, which work together to provide temporary comfort for dry, irritated eyes.

Is REFRESH OPTIVE a controlled substance?

REFRESH OPTIVE is not classified as a controlled substance by the DEA.

What is the generic name for REFRESH OPTIVE?

The generic name for REFRESH OPTIVE is carboxymethylcellulose sodium and glycerin. There are 5 other brand versions of carboxymethylcellulose sodium and glycerin.

What is the NDC code for REFRESH OPTIVE 5 mg/mL?

The NDC (National Drug Code) for REFRESH OPTIVE 5 mg/mL is 0023-3240, listed by Allergan, Inc..

Product NDC

0023-3240

Package NDC

0023-3240-15

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)